Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 19, Issue 5, 2012, Pages 327-331

  Che, W ^a   Liu, W ^b   Wei, Y ^a   Xu, Y ^a   Hou, L ^a   Matsumori, A ^c   Hu, Dayi ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diastolic dysfunction; Echocardiography; HCV infection; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; THICKNESS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SERUM;

EID: 84859807484     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01551.x     Document Type: Article

References (17)

1. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti M. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006; 151(5): 977-984.
2. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005; 96(2): 144-147. (Pubitemid 40209360)
3. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 1997; 96(1): 22-24. (Pubitemid 27298397)
4. Vassalle C, Masini S, Bianchi F, Zucchelli G. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004; 90(5): 565-566. (Pubitemid 38530180)
5. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides:a review. Clin Chem 2004; 50: 30-50.
6. Bassan R, Potsch A, Maisel A. B-type natriuretic peptide: a novel early blood marker of myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005; 26: 234-240. (Pubitemid 40222361)
7. Sabatine MS, Morrow DA, de Lemos JA et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-1995. (Pubitemid 39473283)
8. Wang TJ, Larson M, Levy D et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663. (Pubitemid 38364624)
9. Matsumori A, Shimada T, Chapman N, Tracy S, Maso J. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006; 12(4): 293-298.
10. Antonelli A, Ferri C, Ferrari SM et al. High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. J Viral Hepat 2010; 17(12): 851-853.
11. Januzzi JL Jr, Camargo CA, Anwaruddin S et al. The N-terminal ProBNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95(8): 948-954. (Pubitemid 40487743)
12. Khouri SJ, Maly GT, Suh DD, Walsh T. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 2004; 17: 290-297. (Pubitemid 38879266)
13. Balion CM, Santaguida P, McKelvie R et al. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem 2008; 5: 231-239. (Pubitemid 351240899)
14. Maisel AS, Clopton P, Krishnaswamy P et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 2004; 147: 1078-1084. (Pubitemid 38880968)
15. Wang TJ, Larson MG, Levy D et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600. (Pubitemid 38198866)
16. Bojunga J, Sarrazin C, Hess G, Zeuzem S. Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy. World J Gastroenterol 2006; 12(36): 5875-5877. (Pubitemid 44594258)
17. Wang L, Geng J, Li J et al. The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin Invest Med 2010; 34(1): E30-E37.